Find Academic Supervisors

• Neuroscience
• Neurophysiology
• Systems Neuroscience
• +3 more

Dr. Guanxiao Qi is a researcher at the Institute of Neuroscience and Medicine (INM) and the JARA Institute Brain structure-function relationships (INM-10) at the Research Center Jülich GmbH , Germany. His research focuses on understanding the structure, function, and neuromodulation of brain microcircuits, particularly in cortical layers 4, 6A, and 6B. He employs experimental techniques like paired patch-clamp recordings and computational modeling to study synaptic connectivity, neuromodulatory effects (e.g., acetylcholine, norepinephrine), and the dynamics of neuronal populations. Key areas of investigation include the role of FOXP2 in corticothalamic neurons, nicotinic receptor dysfunction in cortical layers, and the modulation of synaptic transmission by adenosine and cholinergic systems. His work bridges experimental data with algorithmic tools for network analysis, such as the Density visualization pipeline . Dr. Qi’s contributions span from basic neurophysiology to translational studies, addressing questions in systems neuroscience and computational biology. His recent publications (2022–2025) highlight advancements in layered microcircuit models, cell-type-specific neuromodulation, and the functional implications of synaptic plasticity. Collaborations within JARA and the Helmholtz Association position him at the forefront of integrative neuroscience research.

• Neurodegenerative Diseases
• ALS/FTD
• Myotonic Dystrophy
• +4 more

Helene Thuy An Tran serves as an Instructor in the Department of Neurology at the T.H. Chan School of Medicine, UMass Chan Medical School, Worcester, MA, focusing on molecular mechanisms of neurodegenerative disorders including ALS/FTD and myotonic dystrophy. Her academic training includes: BS in Biochemistry from University of Lille, France MS in Molecular Neurobiology from Imperial College London, UK PhD in Molecular Biology from University of Lille, France Dr. Tran's research centers on RNA splicing defects, tau pathology, and oligonucleotide therapeutic development for neurodegenerative conditions. She investigates how C9ORF72 repeat expansions and RNA-binding protein dysregulation (MBNL1/CELF2) drive disease progression in ALS/FTD and myotonic dystrophy using cellular and animal models. Analysis of her 2008-2014 publications reveals consistent expertise in molecular neuropathology, with high-impact work on disease modeling (188 citations for her Acta Neuropathologica paper) and mechanistic insights into spliceopathy-tauopathy interactions. Her research spans proteomics, iPSC-based neuronal modeling, and RNA therapeutics development. Collaborating with leading researchers like Sandra Almeida and Fen-Biao Gao, Dr. Tran contributes to UMass Chan's Neurology Department research ecosystem. Her work demonstrates significant scientific impact through extensive citations and patent references, though specific grant details remain unreported in available sources.

Tomáš FialaView profile

Researcher

• Chemical Biology
• Organic Chemistry
• Bioorganic Chemistry
• +3 more

Dr. Tomáš Fiala is a postdoctoral researcher (Marie Curie Fellow) at the ETH Zürich , Department of Organic Chemistry, Switzerland. He holds a Branco Weiss Fellowship , SNSF Spark Grant , and ETH Career Seed Award for his work on chemical methods targeting brain-immune interfaces and supramolecular systems.

Michelle WuView profile

Professor

• Immunology
• RNA Biology
• Cancer Research
• +3 more

Michelle Wu is a Professor in the Department of Physics at Stanford University's School of Humanities and Sciences. Her research spans immunology, RNA biology, and computational systems biology, with a focus on understanding metabolic pathways in cancer, immune responses in viral infections, and engineered RNA-based molecular systems. Her work integrates multi-omic profiling to identify biomarkers for diseases such as SARS-CoV-2 sequelae and breast cancer metastasis, alongside designing synthetic RNA switches and riboswitches through computational and crowdsourced approaches. Recent studies highlight metabolic dependencies in B-cell leukemia and the development of CAR-T cell therapies for autoimmune diseases. Muhammad Wu's research trends emphasize interdisciplinary methods, combining machine learning with experimental biology to address challenges in molecular engineering and disease mechanisms. No specific awards or grants are listed in the provided texts. Her contributions include advancing RNA thermodynamic modeling and automated design frameworks for biomolecular systems, though no advisees or lab affiliations are explicitly mentioned.

Zepeng YaoView profile

Assistant Professor

• Neuroscience
• Connectomics
• Artificial Intelligence
• +3 more

Assistant Professor Zepeng Yao is a neuroscientist specializing in connectomics and systems biology, contributing to the fruit fly (Drosophila melanogaster) whole-brain connectome project. He is part of the FlyWire Consortium, which published pivotal studies in Nature detailing the brain's neuronal wiring. His research integrates artificial intelligence and open science approaches, engaging researchers, students, and citizen scientists. Key research interests include neuronal connectivity, circadian rhythms, and neuroendocrine regulation. Yao's work bridges AI-driven analysis with biological systems, emphasizing collaborative and reproducible science. His studies span from visual system wiring to metabolic regulation via serotonergic neurons. Notable contributions include the Nature connectome project , the Fly Cell Atlas, and analyses of circadian clock neuron networks. These studies advance understanding of brain structure-function relationships and behavioral regulation in Drosophila.

Dietrich StoutView profile

Professor

• Anthropology
• Paleolithic Archaeology
• Cognitive Neuroscience
• +4 more

Dietrich Stout is a Professor and Chair of the Department of Anthropology at Emory University, serving as Director of the CMBC. He holds a Ph.D. in Paleoanthropology from Indiana University, Bloomington (2003), where he was advised by Nicholas Toth and Kathy Schick. Before joining Emory in 2009, he served as a Visiting Assistant Professor at George Washington University (1 year) and a Lecturer in Paleolithic Archaeology at University College London (4 years). His research focuses on the evolution of human cognition through the study of Paleolithic stone tool-making, integrating archaeological fieldwork, experimental tool replication, and neuroimaging techniques. Collaborative projects include the Homo faber: The Language of Technology (NSF & Templeton Foundation-funded) and the Gona Paleoanthropological Research Project in Ethiopia. Key research themes involve exploring the neural foundations of tool-making, comparing human and chimpanzee brain structures, and investigating the relationship between language, technology, and brain evolution. The Paleolithic Technology Laboratory at Emory supports experimental flintknapping, 3D scanning, and advanced neuroimaging collaborations. Stout's work has been featured in major publications like Science and Scientific American , as well as in Emory's Research Spotlight Video on 'Stone Tools and the Evolution of Cognition.' He advises graduate student Megan Beney and collaborates with a global network of institutions, including the Yerkes National Primate Research Center and the British Museum. His research lab employs cutting-edge technologies such as fMRI, DTI, and PET imaging to study the evolutionary neuroscience of cultural evolution.

Dennis LiottaView profile

Professor

• Medicinal Chemistry
• Antiviral Therapeutics
• Pharmacology
• +4 more

Dennis Liotta, PhD, is the Samuel Candler Dobbs Professor in the Department of Chemistry and Professor in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine. He has served as Chair of the Chemistry Department (1993-1996), Vice President for Research (1996-2000), and Associate Director of the Emory Center for AIDS Research. He co-founded EIDD and DRIVE, critical entities in academic drug development. Education: PhD in Organic Chemistry (1974, City University of New York), Postdoctoral Research (The Ohio State University) Dr. Liotta's research focuses on antiviral therapeutics (HIV, hepatitis B/C), neuropharmacology (NMDA receptor modulators), and oncology (CDK7 inhibitors). His work spans medicinal chemistry , chemical biology , and pharmacological analysis . Recent publications highlight advancements in NMDA receptor modulation for neurological disorders, CXCR4 antagonists for HIV/immunology, and prodrug synthesis techniques for enhanced drug delivery. His team's Molnupiravir development marked a pivotal breakthrough in pandemic response. Scientific Awards Perkin Medal (2022) Wallace H. Carothers Award (2018) Thomas Jefferson Award (2011) Fellow, National Academy of Inventors (2013) Medicinal Chemistry Hall of Fame (2010) As a serial entrepreneur, he co-founded Pharmasset (acquired by Gilead for $11.2B) and over 10 biopharma companies. His leadership in EIDD/DRIVE created academic-commercialization infrastructure for neglected diseases.

Anna MajewskaView profile

Professor

• Neuroscience
• Synaptic Plasticity
• Microglial Dynamics
• +4 more

Anna Majewska, Ph.D., is a Professor in the Department of Neuroscience at the University of Rochester School of Medicine and Dentistry (SMD), affiliated with the Del Monte Institute for Neuroscience and multiple interdisciplinary programs. Her research focuses on synaptic plasticity, microglial dynamics, and neurodegenerative diseases, particularly Alzheimer’s pathology. She holds the Dean’s Professorship and has appointments in multiple departments, including Neurobiology and Anatomy and the Center for Visual Science. Education: B.S. and M.S. in Biology/Chemistry, Stanford University (1992–1996) Ph.D. in Neurobiology and Behavior, Columbia University (1996–2001) Postdoctoral Fellowship, MIT Department of Brain and Cognitive Sciences (2000–2005) Research Interests: Dr. Majewska’s lab investigates synaptic structure-function relationships, microglial roles in neural circuits, and mechanisms underlying Alzheimer’s disease. Her work combines advanced imaging techniques (e.g., two-photon microscopy) with molecular and behavioral approaches to study how microglia interact with synapses during health and disease. Key projects include: Microglial regulation of synaptic plasticity in visual cortex Impact of neuroinflammation on Alzheimer’s pathology Neuroimmune interactions in developmental disorders Recent Articles: Her recent work emphasizes microglial signaling pathways in Alzheimer’s, P2Y12 receptor function in CNS dynamics, and sex-specific microglial responses. These studies bridge basic science and translational research, targeting therapeutic strategies for neurodegenerative diseases. Awards: Kavli Fellow (National Academy of Sciences, 2008) Cajal Club Cortical Explorer Award (2006) Burroughs-Wellcome Fund Career Development Award (2003–2008) Young Scientist Award (Polish Neuroscience Society, 2003) Advising & Grants: Dr. Majewska mentors postdoctoral associates (e.g., MaKenna Cealie, Mark Stoessel) and graduate students (e.g., Linh Le, Elizabeth Plunk). Her lab receives NIH T32 training grants and collaborates with institutions like the Environmental Health Sciences Center and the Neurobiology & Anatomy Ph.D. Program. Labs/Teams: The Majewska Lab is located at the URMC, focusing on cutting-edge imaging techniques and collaborative projects in neuroimmunology and synaptic biology.

• Medical Laboratory Science
• Immune System
• Angiogenesis Inhibitors
• +3 more

Lesley Devine, PhD is a Technical Director at the Yale Flow Core Facility and Scientific Director of the Cancer Center Immune Monitoring Laboratory at Yale School of Medicine. She holds a PhD in Immunology from University College (1995) and a BS in Biochemistry & Immunology from the University of Strathclyde (1991). Her research focuses on immune system mechanisms, cancer biology, and medical laboratory science, with particular expertise in CD8 receptor biology, immune monitoring, and translational research in oncology. She has authored over 20 peer-reviewed articles, including seminal work on CD8-MHC interactions and immune profiling in cancer therapies. Dr. Devine leads core facilities supporting flow cytometry and immune monitoring for Yale's research community. Her recent work includes quantitative DNA repair biomarker studies in colorectal cancer (2023), metabolomic analysis of influenza vaccine responses (2022), and immunological markers in sickle cell disease (2018). She collaborates frequently with oncologists, immunologists, and data scientists at Yale to advance precision medicine and immune-based therapies. Dr. Devine's labs provide cutting-edge technical resources for multidisciplinary research teams across Yale Medicine.

• Neuroscience
• Developmental Neuroscience
• Neurodegenerative Diseases
• +4 more

Zachary Gursky is a Research Fellow in Neuroscience at Yale School of Medicine, specializing in neurodevelopmental disorders and cerebrovascular pathophysiology. His work focuses on the impact of alcohol exposure on brain structures like the thalamic nucleus reuniens and glymphatic system function, with applications to Alzheimer’s disease and fetal alcohol spectrum disorders (FASD). He holds a PhD in Psychological & Brain Sciences from the University of Delaware (2018), an MS in Neuroscience, and a BS in Psychology. Research Interests: Gursky’s studies investigate how developmental alcohol exposure disrupts thalamic circuits, alters CSF flow, and impairs cognitive functions. Using rodent models, he explores mechanisms underlying neurodegeneration and potential therapeutic interventions like exercise-based rehabilitation. Key Contributions: His 2024 study on solute clearance in Alzheimer’s models and 2023 work on CPAP’s effects on glymphatic transport highlight his translational research. Over 20 peer-reviewed publications span FASD neurobiology, cerebrovascular imaging, and neuroplasticity mechanisms. Awards: Recipient of the President’s Young Investigator Award (2018) and multiple travel/fellowship grants from NIH and professional societies. His work bridges basic neuroscience with clinical applications in neurological disorders.

Thomas FathView profile

Professor

• Neurodegenerative Diseases
• Alzheimer's Disease
• Motor Neuron Disease
• +3 more

Prof Thomas Fath is Deputy Director of the Dementia Research Centre and Professor in the Department of Biomedical Sciences at Macquarie University. Previously, he held leadership roles at UNSW Sydney, including Head of the Neurodegeneration and Repair Unit and Neuronal Culture Core Facility. He earned a PhD from Heidelberg University (2002) and has conducted research at prestigious institutions like The Scripps Research Institute and Children's Hospital at Westmead. Education/Academic qualifications include a PhD in Neurobiology (Heidelberg, 2002), Diplom (BSc) in Neurobiology (Heidelberg, 1998), and additional certifications in Data Science and University Learning and Teaching. Research interests focus on the cytoskeleton's role in neurodegenerative diseases, including Alzheimer's, motor neuron disease, and brain trauma. His lab employs cell cultures, genetically modified mice, and advanced imaging to study actin dynamics and tropomyosin isoforms. Current projects target synaptic actin cytoskeleton characterization, actin-based therapies, and neuronal morphogenesis mechanisms. He has secured ARC and NHMRC grants, led multiple projects (e.g., tau spread mechanisms in Alzheimer's), and authored over 80 publications. Recent articles emphasize neuroprotective therapies, actin regulation, and synaptic pathology. Awards include the 2015 Vice Chancellor’s Award for Student Learning Contributions. Editorial roles include Molecular and Cellular Neuroscience and Scientific Reports. He chairs the Australian Society for Biochemistry’s Cell Architecture group.

Haitao YuView profile

Research Fellow

• Physical Chemistry
• Macromolecular and Materials Chemistry
• Materials Engineering
• +6 more

Dr. Haitao Yu is a Research Fellow in the Zhai Group at RMIT University's City Campus in Australia. His research focuses on lipid-based nanocarriers, lyotropic liquid crystalline materials, and their applications in drug delivery, mRNA transfection, and biomedical engineering. He investigates the physicochemical properties of lipid nanoparticles, their interactions with biological systems, and their potential in targeting diseases such as cancer and Alzheimer's. Research Interests: Physical Chemistry of colloidal systems Design of nanomedicine carriers (lipid nanoparticles, cubosomes) pH-responsive materials and self-assembly mechanisms Targeted drug delivery across biological barriers Biochemical interactions of enzymes and nanoparticles Recent Article Trends: His work emphasizes lipid nanoparticle structure-function relationships, mRNA delivery optimization, and overcoming therapeutic challenges through nanotechnology. Key themes include lyotropic liquid crystalline phases, surface functionalization strategies, and in vitro cellular interactions. Advising & Collaboration: Supervises projects on lipid-RNA nanocarrier structure, targeted mRNA delivery systems, and phytotherapeutic approaches for neurodegenerative diseases. Collaborates widely across chemical, biomedical, and materials engineering disciplines. Labs/Teams: Part of the Zhai Group, a multidisciplinary team advancing nanotechnology for healthcare and materials innovation.

• Advanced Materials
• Nanotechnology
• Drug Delivery Systems
• +7 more

Professor Calum Drummond AO is the Deputy Vice-Chancellor (Research and Innovation) and Vice-President at RMIT University. He leads strategic research initiatives, including research partnerships, translation pathways, and the School of Graduate Research. His academic background includes adjunct roles at The University of Queensland, The University of Melbourne, and The University of Sydney. With over 300 publications and 20,000+ citations, his research focuses on advanced materials, drug delivery systems, and ionic liquids. He has received prestigious awards such as the AO honor and the Ian Wark Medal. His work emphasizes commercialization of research outcomes and innovation in biomedical applications. Education: PhD (Implied from career trajectory), declined Rothmans Foundation Fellowship (1990). Research Interests: Nanomaterials, drug delivery, ionic liquids, biomaterials, and lyotropic liquid crystals. Professor Drummond’s leadership spans roles at CSIRO (Group Executive for Manufacturing, Materials, and Minerals) and CAP-XX, where he pioneered supercapacitor technologies. He advises on national research infrastructure and is a Fellow of multiple leadership programs. His labs and teams focus on lipid nanoparticle development for mRNA delivery, cancer therapy, and tissue engineering. Awards: Over 20 major awards, including the Victoria Prize and CSIRO Fellow designation. Grants & Partnerships: Manages RMIT’s research budget and collaborations, with a focus on industry partnerships and innovation.

Pinghua LiuView profile

Professor

• Chemical Biology
• Enzymology
• Isoprenoid Biosynthesis
• +4 more

Pinghua Liu is a Professor at Boston University, specializing in chemical biology at the interface of Chemistry and Biology. His research focuses on enzymology, isoprenoid biosynthesis, and biological clock mechanisms. He leads the Liu Group, which employs advanced techniques such as organic synthesis, spectroscopy, and genetic engineering. Education: B.A. in Chemistry, Nankai University (1993) Masters in Chemical Engineering, Dalian Institute of Chemical Physics (1996) Ph.D. in Bioorganic Chemistry, University of Minnesota (2001) Postdoctoral Associate, MIT (2005) Research Interests: Mechanistic studies of metallo-proteins (IspG/IspH) in isoprenoid biosynthesis Chemical basis of biological clocks and aging processes Development of antibiotics targeting pathogen-host interactions Enzymatic C–S bond formation and oxidative transformations Key Technical Expertise: Enzymology: organic synthesis, protein engineering, and kinetics analysis Genetics: gene knockout, metabolic engineering, and transcriptional regulation Spectroscopies: EPR, Mössbauer spectroscopy, and NMR Lab Opportunities: The Liu Group fosters international collaborations and provides training in both chemistry and biology, preparing students for interdisciplinary careers.

• Diabetic Neuropathy
• Type 1 Diabetes Mellitus
• Neuroscience
• +5 more

Suganthiya Santhiapillai Croosu is a Postdoctoral Researcher at Aalborg University Hospital, working within the Faculty of Medicine's Department of Radiology in Denmark. With an active research career spanning from 2017 to present, Dr. Croosu has contributed significantly to diabetes-related neuroscience and radiological research, with 30 publications to date including journal articles, conference abstracts, and datasets. Dr. Croosu's research primarily focuses on the neurological complications of diabetes, particularly Type 1 Diabetes Mellitus. Key areas include diabetic neuropathy, brain morphometry changes in diabetes, white matter hyperintensities, and corneal confocal microscopy applications. The research employs advanced neuroimaging techniques and quantitative sensory testing to understand the structural and functional changes associated with diabetic complications. This work has important implications for early detection of neuropathic changes and improved patient management strategies. The publication record shows a clear trend toward investigating the intersection of diabetes, neuropathy, and brain structure/function. Recent work (2024-2025) has particularly emphasized diagnostic methods for small fiber damage, brain imaging correlates of diabetic complications, and the relationship between diabetes and cognitive function. These studies frequently employ multimodal approaches combining clinical assessments with advanced imaging techniques. Dr. Croosu actively collaborates with researchers across multiple institutions, as evidenced by co-authorship on numerous publications with colleagues from Aalborg University Hospital and other research centers. The work has garnered citations across multiple platforms, with notable attention in both clinical and research communities. As a researcher in the Department of Radiology within the Faculty of Medicine, Dr. Croosu contributes to a multidisciplinary team investigating the neurological manifestations of diabetes through advanced imaging and clinical assessment techniques. The research program appears to focus on translating imaging findings into clinically useful diagnostic and monitoring tools for diabetic complications.